Detection of occult lymph node metastases in locally advanced node-negative prostate cancer

Vincenzo Pagliarulo, Debra Hawes, Frank H. Brands, Susan Groshen, Jie Cai, John P. Stein, Gary Lieskovsky, Donald G. Skinner, Richard J Cote

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Purpose: The purpose of this study was to determine the incidence and clinical significance of occult metastases in the lymph nodes of patients with prostate cancer originally considered node negative by routine histologic evaluation. Methods: Two hundred seventy four patients with pT3 prostate carcinoma treated by radical prostatectomy and bilateral lymph node dissection were included in this study. One hundred eighty patients were staged node negative (N0), while 94 patients were lymph node positive (N+), based on routine histologic evaluation. All lymph nodes from the 180 N0 patients were evaluated for occult metastases by immunohistochemistry using antibodies to cytokeratins and, if positive, prostate-specific antigen. Recurrence and overall survival were compared among patients with occult tumor cells (OLN+), with patients whose lymph nodes remained negative (OLN-), and with the 94 N+ patients. Results: A total of 3,914 lymph nodes were evaluated from 180 N0 patients (average, 21.7 lymph nodes per patient). Occult tumor cells were found in 24 of 180 patients (13.3%). The presence of OLN+ was significantly associated with increased recurrence and decreased survival compared with OLN-patients(P < .001 and P = .019, respectively; relative risk of recurrence, 2.27; relative risk of death 2.07, respectively). The presence of occult lymph node metastases was an independent predictor of recurrence and death in a multivariable analysis. The outcome for patients with OLN+ disease was similar to that for patients with N+ disease. Conclusion: The detection of occult lymph node metastases in patients with pT3N0 prostate cancer identifies those with significantly increased risk of prostate cancer recurrence and death.

Original languageEnglish
Pages (from-to)2735-2742
Number of pages8
JournalJournal of Clinical Oncology
Volume24
Issue number18
DOIs
StatePublished - Jun 20 2006
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Lymph Nodes
Neoplasm Metastasis
Recurrence
Survival
Prostate-Specific Antigen
Prostatectomy
Keratins
Lymph Node Excision
Prostate
Neoplasms
Immunohistochemistry
Carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. / Pagliarulo, Vincenzo; Hawes, Debra; Brands, Frank H.; Groshen, Susan; Cai, Jie; Stein, John P.; Lieskovsky, Gary; Skinner, Donald G.; Cote, Richard J.

In: Journal of Clinical Oncology, Vol. 24, No. 18, 20.06.2006, p. 2735-2742.

Research output: Contribution to journalArticle

Pagliarulo, V, Hawes, D, Brands, FH, Groshen, S, Cai, J, Stein, JP, Lieskovsky, G, Skinner, DG & Cote, RJ 2006, 'Detection of occult lymph node metastases in locally advanced node-negative prostate cancer', Journal of Clinical Oncology, vol. 24, no. 18, pp. 2735-2742. https://doi.org/10.1200/JCO.2005.05.4767
Pagliarulo, Vincenzo ; Hawes, Debra ; Brands, Frank H. ; Groshen, Susan ; Cai, Jie ; Stein, John P. ; Lieskovsky, Gary ; Skinner, Donald G. ; Cote, Richard J. / Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. In: Journal of Clinical Oncology. 2006 ; Vol. 24, No. 18. pp. 2735-2742.
@article{dc4076174ddf4c31bd95d47aa84dea32,
title = "Detection of occult lymph node metastases in locally advanced node-negative prostate cancer",
abstract = "Purpose: The purpose of this study was to determine the incidence and clinical significance of occult metastases in the lymph nodes of patients with prostate cancer originally considered node negative by routine histologic evaluation. Methods: Two hundred seventy four patients with pT3 prostate carcinoma treated by radical prostatectomy and bilateral lymph node dissection were included in this study. One hundred eighty patients were staged node negative (N0), while 94 patients were lymph node positive (N+), based on routine histologic evaluation. All lymph nodes from the 180 N0 patients were evaluated for occult metastases by immunohistochemistry using antibodies to cytokeratins and, if positive, prostate-specific antigen. Recurrence and overall survival were compared among patients with occult tumor cells (OLN+), with patients whose lymph nodes remained negative (OLN-), and with the 94 N+ patients. Results: A total of 3,914 lymph nodes were evaluated from 180 N0 patients (average, 21.7 lymph nodes per patient). Occult tumor cells were found in 24 of 180 patients (13.3{\%}). The presence of OLN+ was significantly associated with increased recurrence and decreased survival compared with OLN-patients(P < .001 and P = .019, respectively; relative risk of recurrence, 2.27; relative risk of death 2.07, respectively). The presence of occult lymph node metastases was an independent predictor of recurrence and death in a multivariable analysis. The outcome for patients with OLN+ disease was similar to that for patients with N+ disease. Conclusion: The detection of occult lymph node metastases in patients with pT3N0 prostate cancer identifies those with significantly increased risk of prostate cancer recurrence and death.",
author = "Vincenzo Pagliarulo and Debra Hawes and Brands, {Frank H.} and Susan Groshen and Jie Cai and Stein, {John P.} and Gary Lieskovsky and Skinner, {Donald G.} and Cote, {Richard J}",
year = "2006",
month = "6",
day = "20",
doi = "10.1200/JCO.2005.05.4767",
language = "English",
volume = "24",
pages = "2735--2742",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "18",

}

TY - JOUR

T1 - Detection of occult lymph node metastases in locally advanced node-negative prostate cancer

AU - Pagliarulo, Vincenzo

AU - Hawes, Debra

AU - Brands, Frank H.

AU - Groshen, Susan

AU - Cai, Jie

AU - Stein, John P.

AU - Lieskovsky, Gary

AU - Skinner, Donald G.

AU - Cote, Richard J

PY - 2006/6/20

Y1 - 2006/6/20

N2 - Purpose: The purpose of this study was to determine the incidence and clinical significance of occult metastases in the lymph nodes of patients with prostate cancer originally considered node negative by routine histologic evaluation. Methods: Two hundred seventy four patients with pT3 prostate carcinoma treated by radical prostatectomy and bilateral lymph node dissection were included in this study. One hundred eighty patients were staged node negative (N0), while 94 patients were lymph node positive (N+), based on routine histologic evaluation. All lymph nodes from the 180 N0 patients were evaluated for occult metastases by immunohistochemistry using antibodies to cytokeratins and, if positive, prostate-specific antigen. Recurrence and overall survival were compared among patients with occult tumor cells (OLN+), with patients whose lymph nodes remained negative (OLN-), and with the 94 N+ patients. Results: A total of 3,914 lymph nodes were evaluated from 180 N0 patients (average, 21.7 lymph nodes per patient). Occult tumor cells were found in 24 of 180 patients (13.3%). The presence of OLN+ was significantly associated with increased recurrence and decreased survival compared with OLN-patients(P < .001 and P = .019, respectively; relative risk of recurrence, 2.27; relative risk of death 2.07, respectively). The presence of occult lymph node metastases was an independent predictor of recurrence and death in a multivariable analysis. The outcome for patients with OLN+ disease was similar to that for patients with N+ disease. Conclusion: The detection of occult lymph node metastases in patients with pT3N0 prostate cancer identifies those with significantly increased risk of prostate cancer recurrence and death.

AB - Purpose: The purpose of this study was to determine the incidence and clinical significance of occult metastases in the lymph nodes of patients with prostate cancer originally considered node negative by routine histologic evaluation. Methods: Two hundred seventy four patients with pT3 prostate carcinoma treated by radical prostatectomy and bilateral lymph node dissection were included in this study. One hundred eighty patients were staged node negative (N0), while 94 patients were lymph node positive (N+), based on routine histologic evaluation. All lymph nodes from the 180 N0 patients were evaluated for occult metastases by immunohistochemistry using antibodies to cytokeratins and, if positive, prostate-specific antigen. Recurrence and overall survival were compared among patients with occult tumor cells (OLN+), with patients whose lymph nodes remained negative (OLN-), and with the 94 N+ patients. Results: A total of 3,914 lymph nodes were evaluated from 180 N0 patients (average, 21.7 lymph nodes per patient). Occult tumor cells were found in 24 of 180 patients (13.3%). The presence of OLN+ was significantly associated with increased recurrence and decreased survival compared with OLN-patients(P < .001 and P = .019, respectively; relative risk of recurrence, 2.27; relative risk of death 2.07, respectively). The presence of occult lymph node metastases was an independent predictor of recurrence and death in a multivariable analysis. The outcome for patients with OLN+ disease was similar to that for patients with N+ disease. Conclusion: The detection of occult lymph node metastases in patients with pT3N0 prostate cancer identifies those with significantly increased risk of prostate cancer recurrence and death.

UR - http://www.scopus.com/inward/record.url?scp=33745545860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745545860&partnerID=8YFLogxK

U2 - 10.1200/JCO.2005.05.4767

DO - 10.1200/JCO.2005.05.4767

M3 - Article

VL - 24

SP - 2735

EP - 2742

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 18

ER -